- feeds
- popular
- recent
- reader
- about
- story
- technologies
- what is rss
- connect
- dmca
- contact
- Feed Preview Life Sciences Legal Update
Life Sciences Legal Update News; A must-read for all subscribers
After more than 10 years providing updates on a range of topics impacting multinational and global life sciences companies, we’ve made the decision to wind down our Life Sciences Legal Update b...
U.S. Court of Appeals rules AI cannot be named an inventor
According to the U.S. Court of Appeals for the Federal Circuit’s August 5th ruling in Thaler v. Vidal, No. 2021-2347 (Fed. Cir. 2022), artificial intelligence (“AI”) cannot be named as an i...
FDA finalizes guidance on voluntary recalls, issues recommendations for industry
The Food and Drug Administration on March 4 issued new guidance for voluntary recalls of biologics, drugs, devices, and other products. The guidance finalizes an April 2019 draft that advised how...
Join Us: Free CLE Webinar on the Best & Worst Drug/Medical Device Decisions of 2021
It’s that time of year again! The Reed Smith bloggers from the Drug and Device Law Blog will be hosting their annual CLE webinar, “The good, the bad, the ugly: the best and worst prescription...
Health care workers and private employees could be affected by new CMS interim final rule and OSHA final rule
On November 5, 2021, the Centers for Medicare and Medicaid Services (CMS) published an interim final rule that requires vaccinations for certain health care workers. The rule is limited to only t...
Please Join Us: European Life Sciences Legal Insights Month: 4 – 8, 27 October
Reed Smith will be presenting a virtual webinar series highlighting the numerous regulatory, litigation and transactional changes occurring in the European life sciences industry during the month...
Here we go again – Unified Patent Court back on track
The German Constitutional Court issued a landmark decision with implications for many companies doing business in Europe on July 9, 2021. For decades, the European Commission and EU member states...
German Patents Act (PatG) Receives New Updates
Germany recently passed a reform bill for the Patent Act (PatG) and its new provisions will likely be coming into force sooner rather than later. The reform is particularly relevant for companies...
A multi-agency pharmaceutical task force looks to review antitrust issues that arise during mergers and acquisitions
A task force, composed of key antitrust enforcement agencies including the Federal Trade Commission (FTC), and the Canadian Competition Bureau, is seeking information from the public regarding th...
Join Us: Virtual Life Sciences CLE Week for In-House Counsel: November 9-13
Reed Smith is pleased to present a virtual life sciences CLE week from November 9 – 13, covering hot litigation and regulatory topics of interest to our pharmaceutical, biotech, and medical dev...